Stoney Hill Capital

Stoney Hill Capital is dedicated to helping early to mid-stage service and technology providers in the pharmaceutical industry succeed. We invest in established businesses that support the pharmaceutical ecosystem - from clinical development, regulatory services, data and technology platforms, through to commercialization solutions, our team brings deep industry experience, strategic insight, and a powerful network of pharma leaders to every partnership. With the right capital, the right guidance, and the right network we help companies scale smarter, navigate complexity, and unlock their full potential. Our current standout portfolio includes: ▪ Amica Scientific ▪ Advance AI ▪ Nexentria ▪ Verix